Opus Genetics (IRD) Return on Capital Employed Growth (3y) (2021 - 2026)
Opus Genetics (IRD) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -356.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -516.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -2,309.00 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4,967.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,424.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 513.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5,777.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 109.00 |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - | -11,696.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11,696.00 |
| Mar 31, 2026 | -13,073.00 |
| Dec 31, 2025 | -17,182.00 |
| Sep 30, 2025 | -62,119.00 |
| Jun 30, 2025 | -14,195.00 |
| Mar 31, 2025 | -23,231.00 |
| Dec 31, 2024 | -11,789.00 |
| Sep 30, 2024 | 6,093.00 |
| Jun 30, 2024 | 14,279.00 |
| Mar 31, 2024 | 15,224.00 |
| Dec 31, 2023 | 17,712.00 |
| Sep 30, 2023 | 7,898.00 |
| Jun 30, 2023 | 6,289.00 |
| Mar 31, 2023 | 10,702.00 |
| Dec 31, 2022 | -37,325.00 |
| Sep 30, 2022 | -5,710.00 |
| Jun 30, 2022 | -2,688.00 |
| Mar 31, 2022 | 238.00 |
| Dec 31, 2021 | 6,472.00 |